Cellectar Biosciences(DE:NV40)
€0.290.00 (0.00%)
DE:NV40
Cellectar Biosciences earnings date
€0.29
At close:0.00 (0.00%)
Cellectar Biosciences (NV40) Q3 2022 Earnings Report
1 Followers
DE:NV40 Q3 2022 EPS Results
- Actual EPS
- -EUR 34.71
- Consensus EPS
- -EUR 34.08
- Beat/Miss
- Missed by -EUR 0.63
- One Year Ago EPS
- -EUR 27.12
DE:NV40 Q3 2022 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/03/2022
- Time
- Before Open
- Conference Call
- Thursday, November 3, 2022
DE:NV40 Upcoming Earnings
Cellectar Biosciences's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:NV40 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | -0.44- | 0.59 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.50-0.42 | -1.27 | 67.38% (+0.86) | |
| Aug 13, 2026 | 2026 (Q2) | -0.47-0.52 | -3.06 | 83.19% (+2.55) | |
| May 14, 2026 | 2026 (Q1) | -1.70-1.20 | -3.8 | 68.33% (+2.59) | |
| Mar 04, 2026 | 2025 (Q4) | -1.110.59 | -1.9 | 130.95% (+2.49) | |
| Nov 13, 2025 | 2025 (Q3) | -2.28-1.27 | -10.85 | 88.25% (+9.57) | |
| Aug 14, 2025 | 2025 (Q2) | -3.36-3.06 | -4.88 | 37.22% (+1.82) | |
| May 13, 2025 | 2025 (Q1) | -4.43-3.80 | -20.07 | 81.08% (+16.27) | |
| Mar 13, 2025 | 2024 (Q4) | -9.56-1.90 | -11.12 | 82.93% (+9.22) | |
| Nov 18, 2024 | 2024 (Q3) | -8.95-10.85 | -23.58 | 53.99% (+12.73) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
